Benzinga | Sep 9, 2021 06:26AM EDT

SVB Leerink Initiates Coverage On scPharmaceuticals with Market Perform Rating, Announces Price Target of $6

SVB Leerink analyst Roanna Ruiz initiates coverage on scPharmaceuticals (NASDAQ:SCPH) with a Market Perform rating and announces Price Target of $6.